Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (22,257) $ (13,200)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 152 65
Loss on change in estimated fair value of contingent royalty obligation 291 252
Share based compensation 2,475 2,220
Amortization of bond premium 33
Warrant expense 3,156
Inventory write-down 364 72
Write-down of workstations related to evaluation agreements 332
Changes in operating assets and liabilities:    
Accounts receivable (5)
Inventory (381) 3
Prepaid expenses and other current assets 69 (476)
Accounts payable and accrued expenses 744 210
Other current and non-current liabilities 94 456
Net cash used in operating activities (14,933) (10,398)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of fixed assets (547) (707)
Repayment from long-term deposits (44)
Repayment of shareholder loan receivable 126
Purchase of available-for-sale securities (5,043)
Proceeds from sale of available-for-sale securities 2,000
Purchase of held-to-maturity securities (4,863)
Proceeds from sale of held-to-maturity securities 4,830
Net cash used in investing activities (3,497) (751)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from public offerings 31,000
Proceeds from exercise of over-allotment options 2,305  
Proceeds from exercise of options 48
Proceeds from issuance of shares, net of financing costs of $851 6,474
Financing fees (3,812) (37)
Net cash provided by financing activities 29,541 6,437
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 11,111 (4,712)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 6,939 11,651
CASH AND CASH EQUIVALENTS AT END OF PERIOD 18,050 6,939
CASH PAID FOR:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Reclassification of deferred financing costs from current assets to common stock 602
Cashless exercise of options 2
Financing fees included in accounts payable and accrued expenses $ 207 $ 565